| Recruiting | A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxi AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category) | Phase 2 | 2025-07-25 |
| Active Not Recruiting | HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantati Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia | Phase 2 | 2023-12-08 |
| Active Not Recruiting | Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events Acute Myeloid Leukemia in Remission | — | 2022-08-26 |
| Active Not Recruiting | HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia | Phase 2 | 2021-09-30 |
| Active Not Recruiting | Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With R Acute Myelogenous Leukemia | Phase 1 / Phase 2 | 2020-01-08 |
| Completed | Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704) Hematologic Malignancy | — | 2019-07-19 |
| Completed | Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes | N/A | 2019-06-14 |
| Completed | Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors Quality of Life | — | 2019-04-03 |
| Active Not Recruiting | Conditioning SCID Infants Diagnosed Early SCID | Phase 2 | 2018-10-22 |
| Completed | Study of Quality of Life in Older vs. Younger Adult Patients Undergoing Allogeneic Hematopoietic Cell Transpla Myelodysplastic Syndromes, Hematopoietic Cell Transplant | — | 2018-07-23 |
| Recruiting | Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma Multiple Myeloma | — | 2017-07-25 |
| Terminated | Generation of an Induced Pluripotent Stem (iPS) Cell Bank Immune Matched to a Majority of the US Population iPS Cell Manufacture and Banking | N/A | 2017-01-13 |
| Completed | HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Chemotherapy-sensitive Lymphoma | Phase 2 | 2016-12-01 |
| Recruiting | Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis Myelofibrosis | — | 2016-11-01 |
| Terminated | Moxetumomab Pasudotox (CAT-8015, HA22) in Children With B-lineage Acute Lymphoblastic Leukemia and Minimal Res Acute Lymphoblastic Leukemia (ALL) | Phase 2 | 2015-05-01 |
| Completed | Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors Adult Hematopoietic Cell Transplant (HCT) Survivors 1-2 Yrs Post Most Recent HCT | N/A | 2015-04-01 |
| Unknown | Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood He Acute Lymphoblastic Leukemia/Lymphoma, Myelodysplasia, Acute Myelogenous Leukemia | — | 2015-03-01 |
| Completed | Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) | Phase 2 | 2013-09-01 |
| Completed | A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor Related Donors Donating Peripheral Blood Stem Cells (PBSC) to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | 2013-05-01 |
| Recruiting | A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets | — | 2011-10-01 |
| Completed | MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia Acute Myeloid Leukemia | — | 2011-10-01 |
| Completed | Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Databa Hematopoietic Stem Cell Transplantation | — | 2011-07-01 |
| Completed | National Marrow Donor Program Long-Term Donor Follow-Up Hematologic Neoplasms | — | 2010-10-01 |
| Completed | Stem Cell Related Donor Safety Study Related Hematopoietic Stem Cell Donors | — | 2010-01-01 |
| Completed | The Financial Impact of Allogeneic Stem Cell Transplantation on Patient and Family Financial Impact of Stem Cell Transplantation | — | 2009-03-01 |
| Completed | Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma Multiple Myeloma | Phase 2 | 2009-02-01 |
| Completed | Adult Double Cord Blood Transplant Study Cord Blood Stem Cell Transplantation, Hematologic Malignancies | Phase 2 | 2007-08-01 |
| Terminated | Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma Metastatic Renal Cell Carcinoma | Phase 2 | 2006-04-01 |
| Recruiting | CIBMTR Research Database Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Solid Tumors | — | 2002-07-01 |
| Recruiting | Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors Healthy | Phase 3 | 1997-02-01 |
| Recruiting | Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Cellular Therapy | — | 1991-07-01 |